2nd Quarter - Amendment

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$432,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 16, 2010 $790,000 Replaced
2nd Quarter - Amendment Jul 16, 2010 $857,000 Replaced
2nd Quarter - Amendment (this page) Apr 20, 2011 $432,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Animal and Plant Health Inspection Service/Center for Veterinary Biologics; veterinary labeling issues

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
CANDIE PHIPPS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

340B (Medicaid) Expansion

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Patent Reform; Patent Settlements; H.R. 1706 and S. 5369

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 5369 (111th), H.R. 1706 (111th)

Health Issues HCR

Health care reform; Patient Protection and Affordable Care Act implementation - pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; Prescription Drug User Fee Act Reauthorization

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare, Medicaid and Medicaid Expansion in health reform 340B (Medicaid) pricing in Tax Extenders (H.R. 4213)

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4213 (111th)

Budget/Appropriations BUD

Supplimentatl Appropriations Bill - patent settlements (no bill number at this stage)

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Tariff (miscellaneous tariff bills) TAR

Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid

LobbyistCovered position, as disclosed
CANDIE PHIPPS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.